Gilead Sciences, Inc.
GILDLast close · Oct 16, 2026156.19−1.18 (−0.75%)
Market cap$193.7B
Key indicators
Revenue30.5B+5.5% on a year earlier
22.1B
22.4B
24.7B
27.3B
27.3B
27.1B
28.8B
29.4B
30.5B
30.7B
32.9B
34.6B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 22.1B | 22.4B+1.5% | 24.7B+10.0% | 27.3B+10.6% | 27.3B−0.1% | 27.1B−0.6% | 28.8B+6.0% | 29.4B+2.4% | 30.5B+5.5% | 30.7B | 32.9B | 34.6B | |
| — | 1.5% | 10.0% | 10.6% | -0.1% | -0.6% | 6.0% | 2.4% | 5.5% | 4.4% | 6.9% | 5.4% | |
| $4.17 | $4.22+1.2% | $0.10−97.6% | $4.93+4830.0% | $3.64−26.2% | $4.50+23.6% | $0.38−91.6% | $6.78+1684.2% | -$2.66−153.3% | -$0.41 | $9.99 | $10.78 | |
| Profitability | ||||||||||||
| 37.1% | 19.1%−18.0 pt | 16.5%−2.6 pt | 36.3%+19.8 pt | 26.9%−9.5 pt | 28.0%+1.2 pt | 5.8%−22.3 pt | 34.0%+28.3 pt | -8.2%−36.1 pt | · | · | · | |
| 24.7% | 24.0%−0.7 pt | 0.5%−23.5 pt | 22.8%+22.3 pt | 16.8%−6.0 pt | 20.9%+4.1 pt | 1.7%−19.2 pt | 28.9%+27.2 pt | -10.6%−32.5 pt | · | · | · | |
| 25.5% | 23.9%−1.6 pt | 0.7%−23.2 pt | 29.5%+28.9 pt | 21.6%−7.9 pt | 24.8%+3.2 pt | 2.5%−22.3 pt | 37.5%+35.0 pt | — | · | · | · | |
| Cash | ||||||||||||
| 7.5B | 8.3B+11.3% | 7.5B−9.6% | 10.8B+43.7% | 8.3B−22.8% | 7.4B−11.1% | 10.3B+38.9% | 9.5B−8.2% | 12.9B+38.1% | · | · | · | |
| 33.8% | 37.1%+3.3 pt | 30.5%−6.6 pt | 39.6%+9.1 pt | 30.6%−9.0 pt | 27.4%−3.2 pt | 35.8%+8.5 pt | 32.1%−3.7 pt | 42.5%+10.0 pt | · | · | · | |
| 3.0B | 3.2B+8.4% | 3.4B+7.0% | 3.6B+4.5% | 3.7B+2.9% | 3.8B+2.7% | 3.9B+2.9% | 4.0B+2.2% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 1.28x | 1.09x−0.19x | 1.73x+0.63x | 1.27x−0.46x | 1.19x−0.08x | 1.09x−0.09x | 1.38x+0.29x | 1.10x−0.28x | 2.22x+0.95x | · | · | · | |
| 1.31B | 1.28B−2.4% | 1.26B−1.1% | 1.26B−0.1% | 1.26B+0.0% | 1.26B−0.3% | 1.25B−0.2% | 1.25B+0.0% | 1.24B−1.0% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.